Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid hormone replacement after congenital heart surgery in infants with postoperative euthyroid sick syndrome
ChiCTR2400093391Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Nanjing Medical University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levothyroxine sodium in euthyroid sick syndrome (NTIS) (2 arms), sponsored by Children's Hospital of Nanjing Medical University. Primary endpoints: Postoperative left ventricular ejection fraction and Length of hospitalization. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on ChiCTR2400093391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093391.